This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. More information in our Privacy Policy
DRUG-MOLECULE
Enlarging cancer research knowledge and medication discovery of novel drugs and novel targets for cancer therapy
Principal Investigator: Silvia Panseri
Involved Personnel: Monica Montesi, Giada Bassi, Arianna Rossi
Starting date: 01/11/2020
Duration: 24 month
Total Funding: 390.000 €
Action: National Program “European Scientific Networks” – Bulgarian Ministry of Education and Science
CNR-ISTEC role: Partner
Coordinator: Prof. Emilia Naydenova (University of Chemical Technology and Metallurgy, Bulgaria)
Consortium: 4 partners (University of Chemical Technology and Metallurgy, ISTEC, Sunbay, Medical Univeristy of Vienna)
Sito ufficiale: www.drug-molecule.com
The main aim of DRUG-MOLECULE is to enhance the research conducted at Departments of Organic Chemistry and Biotechnology of the University of Chemical Technology and Metallurgy (UCTM) in Bulgaria through targeted twinning activities with two internationally-leading research institutions, namely the Austrian Institute of Technology (AIT) and the Italian National Research Council (CNR).
In particular, the aim will be to stimulate excellence and innovation capacity at UCTM primarily in the field of medicinal chemistry and drug discovery. Twinning activities will include knowledge transfer and exchange of best practices between AIT/ CNR and UCTM. This project will entail significant benefits for all institutions involved in terms of enhancement of their Research and Innovation (R&I) capacity in science and technology and raising their staff’s research profile.